UNICA IRIS Institutional Research Information System

MACCIO', ANTONIO PIETRO MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 125.797
NA - Nord America 11.452
AS - Asia 4.361
SA - Sud America 762
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
AN - Antartide 2
Totale 142.485
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 122.778
US - Stati Uniti d'America 11.308
CN - Cina 1.734
SG - Singapore 1.730
UA - Ucraina 913
SE - Svezia 727
BR - Brasile 613
DE - Germania 430
GB - Regno Unito 309
VN - Vietnam 306
FI - Finlandia 231
KR - Corea 159
FR - Francia 122
IN - India 109
HK - Hong Kong 89
CA - Canada 86
AR - Argentina 66
RU - Federazione Russa 51
NL - Olanda 48
AT - Austria 33
BD - Bangladesh 33
MX - Messico 33
ID - Indonesia 32
PL - Polonia 31
ZA - Sudafrica 31
EC - Ecuador 26
IE - Irlanda 23
ES - Italia 22
JP - Giappone 22
TR - Turchia 22
IR - Iran 17
PK - Pakistan 14
MA - Marocco 13
BE - Belgio 12
CO - Colombia 12
EG - Egitto 12
IQ - Iraq 11
TH - Thailandia 10
UZ - Uzbekistan 10
CH - Svizzera 9
EU - Europa 9
PH - Filippine 9
UY - Uruguay 9
VE - Venezuela 9
LT - Lituania 8
RO - Romania 8
SA - Arabia Saudita 8
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
KE - Kenya 7
PE - Perù 7
PY - Paraguay 7
BG - Bulgaria 6
KZ - Kazakistan 6
TN - Tunisia 6
AU - Australia 5
BO - Bolivia 5
JO - Giordania 5
LK - Sri Lanka 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HU - Ungheria 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CR - Costa Rica 3
GR - Grecia 3
LB - Libano 3
MU - Mauritius 3
MY - Malesia 3
PT - Portogallo 3
AO - Angola 2
AQ - Antartide 2
BB - Barbados 2
BZ - Belize 2
CI - Costa d'Avorio 2
CM - Camerun 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
MG - Madagascar 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
Totale 142.473
Salva come PNG Salva come JPEG
Città #
Cagliari 118.814
Uta 3.362
Fairfield 1.281
Woodbridge 1.096
Ashburn 908
Houston 760
Singapore 755
Dallas 688
Chandler 623
Boardman 588
Nyköping 543
Seattle 535
Ann Arbor 534
Jacksonville 517
Wilmington 504
Cambridge 419
Beijing 330
Dearborn 224
New York 214
Hefei 180
Nanjing 165
Boston 159
Los Angeles 155
Santa Clara 138
Seoul 137
Buffalo 103
Ho Chi Minh City 97
San Diego 88
Helsinki 86
Hong Kong 83
Guangzhou 78
Shanghai 78
The Dalles 71
Dong Ket 68
Milan 60
London 59
Menlo Park 57
Shenyang 52
Hanoi 50
São Paulo 44
Redwood City 43
Nanchang 42
Redondo Beach 42
Changsha 41
Toronto 38
Tianjin 36
Nuremberg 35
Rome 33
Hebei 32
Jiaxing 32
Chicago 30
Jinan 30
Pune 30
Norwalk 28
Atlanta 27
Verona 27
Phoenix 25
Frankfurt am Main 24
Warsaw 23
Mountain View 22
Munich 22
Orange 22
Rio de Janeiro 22
Council Bluffs 20
Zhengzhou 20
Vienna 19
Chennai 18
Johannesburg 18
Tokyo 18
Montreal 17
Auburn Hills 16
Hangzhou 15
Denver 14
Amsterdam 13
Belo Horizonte 13
Brooklyn 13
San Francisco 13
Sassari 13
Wuhan 13
Brussels 12
Columbus 12
Ningbo 12
Ankara 10
Kunming 10
Lappeenranta 10
Orem 10
Xi'an 10
Bangkok 9
Buenos Aires 9
Düsseldorf 9
Guayaquil 9
Haiphong 9
Mumbai 9
Poplar 9
Saint Petersburg 9
Stockholm 9
Brasília 8
Jakarta 8
Manchester 8
Charlotte 7
Totale 135.860
Salva come PNG Salva come JPEG
Nome #
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.289
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.483
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.427
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.407
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.230
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.174
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.168
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 2.037
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 1.996
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.930
Advances in pharmacologic strategies for cancer cachexia 1.873
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.843
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.832
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.777
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.757
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.750
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.745
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.709
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.707
Successful laparoscopic management of a giant ovarian cyst 1.707
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.698
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.697
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.687
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.684
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.652
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.646
Surprising results of a supportive integrated therapy in myelofibrosis 1.581
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.552
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.551
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.549
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.514
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.507
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.453
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.443
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.383
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.343
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.287
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.191
Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer 1.129
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.119
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.022
null 998
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 978
Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy 977
Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer 934
Blocking inflammation to improve immunotherapy of advanced cancer 932
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 911
Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients 884
Laparoscopic management of a giant mucinous benign ovarian mass weighing 10150 grams: A case report 874
The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications - a review 850
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 846
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 845
Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer 826
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 820
null 819
Three cases of laparoscopic myomectomy performed during pregnancy for pedunculated uterine myomas 817
Successful pregnancy following myomectomy of a giant uterine myoma: role of a combined surgical approach 795
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 778
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 769
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 767
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 762
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 755
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 745
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 737
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 723
Antioxidant agents alpha lipoic acid, N-Acetyl cysteine and MESNA (2-mercaptoethane sulfonate) are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients 710
null 709
Experimental drugs for chemotherapy-and cancer-related anemia 709
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 675
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 666
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 665
Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients 664
Novel technique of extracorporeal intrauterine morcellation after total laparoscopic hysterectomy: Three emblematic case reports 659
Randomised Phase III Clinical Trial of a Combined Treatment With Carnitine plus Celecoxib +/- Megestrol Acetate for Patients With Cancer-related Anorexia/cachexia Syndrome 634
Laparoscopic management of isolated nodal recurrence in gynecological malignancies is safe and feasible even for large metastatic nodes up to 8 cm: A prospective case series 626
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 608
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 606
Managing cancer-related anorexia/cachexia 601
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 596
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 586
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 581
The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone 577
Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation 572
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 561
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 556
Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer 556
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 555
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 551
Multitargeted treatment of cancer cachexia 546
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 542
Cachexia and oxidative stress in cancer: an innovative therapeutic management 542
A phase II study with antioxidants, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia (CACS) and oxidative stress (OS) 539
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS): Interim results 537
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 534
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 531
Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease 529
Current pharmacotherapy options for cancer anorexia and cachexia 517
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life 517
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report 516
Antioxidant therapy for the treatment of oxidative stress associated to cancer and cancer-related anorexia/cachexia 516
Totale 112.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114.962 0 0 0 0 0 4.501 3.242 2.424 776 1.621 1.487 911
2021/20227.039 551 514 450 439 721 447 469 481 605 537 702 1.123
2022/202313.188 1.054 1.398 1.168 1.001 925 1.437 747 1.423 965 978 1.353 739
2023/202415.777 994 639 532 1.061 1.520 2.821 2.198 1.004 749 1.070 1.661 1.528
2024/202519.825 2.461 3.737 3.090 3.232 1.625 2.406 1.441 195 422 396 404 416
2025/20264.958 608 540 1.417 1.005 755 633 0 0 0 0 0 0
Totale 142.988